Medical specialists from France tagged as investigators in clinical trials studying Anemia, Refractory, with Excess of Blasts

Total 29 results

A. Banos
Seen in:
- Bayonne, FR-Bayonne-CHCOTEBASQUE
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
A. Villate
Seen in:
- Tours, FR-Tours cedex-BRETONNEAU
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
Ahmad AL JIJAKLI
Seen in:
- Argenteuil, CH Victor Dupouy
- Argenteuil, FR-Argenteuil-CHARGENTEUIL
Trials:
- NCT04027309 (Principal Investigator)
- NCT05444712 (Principal Investigator)
Conditions:
Ambroise Marcais
Seen in:
- Paris, FR-Paris cedex 15-NECKER
- Paris, Hopital Necker
Trials:
- NCT04027309 (Principal Investigator)
- NCT05444712 (Principal Investigator)
- NCT05260528 (Principal Investigator)
Conditions:
Amine Belhabri
Seen in:
- Lyon, FR-Lyon-LEONBERARD
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
Arnaud Jaccard
Seen in:
- Limoges, CHU de Limoges
- Limoges, FR-Limoges-CHULIMOGES
Trials:
- NCT04027309 (Principal Investigator)
- NCT05260528 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
Arnaud Pigneux
Seen in:
- Pessac, CHU de Bordeaux - Hopital Haut-Lévêque
- Pessac, FR-Pessac Cedex-CHUBORDEAUX
- Pessac, Magendie Hopital Haut-Leveque
Trials:
- NCT04027309 (Principal Investigator)
- NCT04905407 (Principal Investigator)
- NCT04067336 (Principal Investigator)
Conditions:
B. Lioure
Seen in:
- Strasbourg, FR-Strasbourg cedex-HAUTEPIERRE
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
Bruno Quesnel
Seen in:
- Lille, FR-Lille-CHULILLE
- Lille, Hôpital Claude HURIEZ, CHU Lille
Trials:
- NCT04027309 (Principal Investigator)
- NCT05260528 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
C.E. Bulabois
Seen in:
- Grenoble cedex 9, FR-Grenoble cedex 9-CHUGRENOBLE
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
Chantal Himberlin
Seen in:
- Reims, FR-Reims-CHREIMS
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
Delphine Lebon
Seen in:
- Amiens, CHU Amiens Picardie site Sud
- Amiens, CHU Amiens-Picardie
- Amiens, FR-Amiens-CHUAMIENS
Trials:
- NCT04797780 (Principal Investigator)
- NCT04027309 (Principal Investigator)
- NCT05260528 (Principal Investigator)
Conditions:
E. Gehlkopf
Seen in:
- Montpellier, FR-Montpellier-STELOI
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
E. Tavernier
Seen in:
- Saint-Priest-en-Jarez, FR-Saint-Priest-en-Jarez-ICLOIRE
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
Emilie Lemasle
Seen in:
- Rouen, FR-Rouen cedex-BECQUEREL
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
G. Roth-Guepin
Seen in:
- Vandœuvre-lès-Nancy, FR-Vandoeuvre Les Nancy-CHRUNANCY
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
Herve Dombret
Seen in:
- Paris, FR-Paris cedex 10-SAINTLOUIS
- Paris, Hoiptal St Louis
Trials:
- NCT04027309 (Principal Investigator)
- NCT00424229 (Principal Investigator)
Conditions:
Jean-Valere Malfuson
Seen in:
- Clamart, FR-Clamart-HIAPERCY
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
Jeanbaptiste Micol
Seen in:
- Villejuif, FR-Villejuif-GUSTAVEROUSSY
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
M. Hunault-Berger
Seen in:
- Angers, FR-Angers-CHUANGERS
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
Marc Bernard
Seen in:
- Rennes, FR-Rennes cedex 9-CHURENNES
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
Maria-Pilar Gallego Hernanz
Seen in:
- Poitiers, FR-Poitiers-CHUPOITERS
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
N. Vey
Seen in:
- Marseille, FR-Marseille-IPC
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
P.H. Rousselot
Seen in:
- Chesnay, FR-Le Chesnay cedex-CHVERSAILLES
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
Pierre Peterlin
Seen in:
- Nantes, CHU de Nantes
- Nantes, FR-Nantes-CHUNANTES
Trials:
- NCT04027309 (Principal Investigator)
- NCT04067336 (Principal Investigator)
Conditions:
R. Guieze
Seen in:
- Clermont-Ferrand, FR-Clermont-Ferrand-ESTAING
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
T. Cluzeau
Seen in:
- Nice, FR-Nice-LARCHET
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
Thorsten Braun
Seen in:
- Bobigny, FR-Bobigny-AVICENNE
- Bobigny, Hôpital Avicenne
- Bobigny, Hôpital Avicenne APHP
Trials:
- NCT04797780 (Principal Investigator)
- NCT04027309 (Principal Investigator)
- NCT05260528 (Principal Investigator)
Conditions:
Y. Desbrosses
Seen in:
- Besançon, FR-Besançon Cedex-JEANMINJOZ
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2

Clinical Trials on Anemia, Refractory, with Excess of Blasts

Onconova Therapeutics, Inc.

Terminated

Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA (INSPIRE)

Myelodysplastic Syndrome | MDS | Refractory Anemia With Excess Blasts | RAEB

United States, Spain, Canada, France, Australia, Switzerland, Israel, Japan, Belgium, India, Ireland, United Kingdom, Croatia, Czechia, Poland, Estonia, Germany, Italy, Austria, Hungary, Russian Federation, Sweden
Boston Children's Hospital

Completed

Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT

AML | ALL | Biphenotypic Leukemia | Refractory Anemia | Refractory Cytopenia With Multilineage Dysplasia | Refractory Anemia With Ringed Sideroblasts | Undifferentiated Leukemia | Ref. Cytopenia w Multilineage Dysplasia & Ringed Sideroblasts | Refractory Anemia With Excess Blasts-1 (5-10% Blasts) | Refractory... and other conditions

United States
National Cancer Institute (NCI)

Completed

Tipifarnib in Treating Patients With Myelodysplastic Syndromes

Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndromes | de Novo Myelodysplastic Syndromes | Refractory Anemia | Refractory Anemia With Excess Blasts | Refractory Cytopenia With Multilineage Dysplasia | Refractory Anemia With Excess Blasts in Transformation | Refractory Anemia...

United States
Central Hospital, Nancy, France
Inserm U954 - N-GERE (Nutrition, Genetics and Exposition to Environmental...

Unknown

High Risk Myelodysplasia Treated by Azacytidine : Genetic and Epigenetic (MYRAGE) (MYRAGE)

High-risk Myelodysplastic Syndromes With Excess Blasts

France
National Cancer Institute (NCI)

Completed

Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy

Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Previously Treated Myelodysplastic Syndromes | Refractory Anemia With Excess Blasts | Refractory Anemia With Excess Blasts in Transformation

United States
National Cancer Institute (NCI)

Completed

Thalidomide in Treating Patients With Myelodysplastic Syndrome

Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic Syndromes | Refractory Anemia | Refractory Anemia With Excess Blasts | Refractory Anemia With Excess Blasts in Transformation | Refractory Anemia With Ringed...

United States
Onconova Therapeutics, Inc.

Completed

Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine

Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Cytopenia | Refractory Anemia With Excess Blasts

United States, Australia, Spain, Italy, Germany, France, Sweden, Denmark
Skyline Diagnostics BV
Illumina, Inc.

Terminated

Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler

Acute Myeloid Leukemia (AML) | Acute Promyelocytic Leukemia (APL) | Refractory Anemia With Excess of Blasts (RAEB)

United States, Germany, Netherlands, United Kingdom
Ruijin Hospital

Recruiting

Evaluate the Efficacy and Safety of Allogeneic Haematopoietic Stem Cell Transplantation With FBM Conditioning for MDS

Myelodysplastic Syndromes | Myelodysplastic Syndrome With Excess Blasts-2 | Myelodysplastic Syndrome With Excess Blasts-1

China
National Cancer Institute (NCI)

Completed

Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes

Unspecified Childhood Solid Tumor, Protocol Specific | Childhood Myelodysplastic Syndromes | Previously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic Syndromes | Refractory Anemia | Refractory Anemia With Excess Blasts | Refractory Cytopenia With... and other conditions

United States

Medical specialists from France tagged as investigators in clinical trials studying Anemia, Refractory, with Excess of Blasts

Clinical Trials on Anemia, Refractory, with Excess of Blasts

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations